CYPB Cypress Bioscience Inc
Company profile
Ticker
CYPB
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Amgen • Gilead Sciences • Biogen • QIAGEN • Moderna • BioNTech SE • Bio-Techne • Enzon Pharmaceuticals • Denali Therapeutics • Allogene Therapeutics ...
Former names
Imre Corp
SEC CIK
Corporate docs
IRS number
222389839
Calendar
9 Nov 10
29 Sep 20
31 Dec 20
News
Financial report summary
?
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
addiction, addressing, aerosol, affiliate, agent, al, Alexza, analog, andStaccatonicotine, anniversary, apprise, attach, autism, banking, behavioral, Biotech, breakthrough, buy, capability, capable, carbetocin, carcinogenicity, Chancery, COBRA, commercializeStaccato, commercializingStaccatonicotine, complaint, consummated, core, daily, David, declared, deep, defective, deliver, delivering, description, deter, developingStaccatonicotine, developmental, developStaccatonicotine, disposal, dividend, embedded, enjoin, Exagen, expert, exploration, explore, faith, Ferring, fiduciary, formal, forStaccatonicotine, hemorrhage, holder, hormone, hostile, illusory, incurrence, inhalation, inhaled, injury, innovativeStaccatonicotine, inquiry, inStaccatonicotine, intangible, intranasal, Ireland, Junior, leave, licensor, manufactureStaccato, Marina, maximize, mimicking, monetary, monetization, movement, multidose, nicotine, Notification, occurrence, ofStaccatonicotine, oral, ordinary, orStaccatonicotine, outsource, oxytocin, par, parenteral, people, pill, pilot, plaintiff, poison, possession, postpartum, precision, preferred, proceed, produceStaccatonicotine, psychological, purportedly, put, QSR, reacquire, reclassified, recommendation, rejected, Retraining, reveal, salt, Savellafor, Savellashould, scheduled, segregated, sellingStaccatonicotine, shareholder, smoking, solve, split, Staccato, Staccatonicotine, straight, theStaccato, theStaccatodelivery, thestaccatonicotine, TheStaccatotechnology, titrate, top, toStaccatonicotine, toxicology, transdermal, true, Trust, unannounced, unpredictable, unspecified, upward, withStaccatonicotine, Worker
Removed:
activation, approvedSavellafor, autoimmune, avise, began, calling, Cellatope, CMS, commercializeSavella, commercializeSavellawill, complement, debilitating, determination, diagnose, expended, field, forSavella, forSavellaand, forSavellafor, forSavellareceived, forSavellashould, guaranteed, improving, inSavella, integrated, leader, MCV, Medicare, monitor, monitoring, ofSavella, ofSavellaand, ofSavelladuring, ofSavellafor, ofSavellaif, ofSavellain, ofSavellaor, ofSavellawhich, PG, PGandAvise, platform, secure, seeking, seizure, shipping, SM, systemic, thereforeSavellamay, toSavella, validated, validation, withSavella, withSavellaand, withSavellafor
Financial reports
10-Q
2010 Q3
Quarterly report
9 Nov 10
10-Q
2010 Q2
Quarterly report
9 Aug 10
10-Q
2010 Q1
Quarterly report
10 May 10
10-K
2009 FY
Annual report
31 Mar 10
NT 10-K
Notice of late annual filing
16 Mar 10
10-Q
2009 Q3
Quarterly report
9 Nov 09
10-Q
2009 Q2
Quarterly report
10 Aug 09
10-Q
2009 Q1
Quarterly report
11 May 09
10-K
2008 FY
Annual report
16 Mar 09
10-Q
2008 Q3
Quarterly report
10 Nov 08
Current reports
8-K
Departure of Directors or Certain Officers
22 Dec 10
8-K
Entry into a Material Definitive Agreement
16 Dec 10
8-K
Cypress Bioscience Agrees to Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share In Cash
15 Dec 10
8-K
Results of Operations and Financial Condition
9 Nov 10
8-K
Cypress Bioscience Announces Agreement to Sell Diagnostic Business to Exagen Diagnostics
8 Oct 10
8-K
Entry into a Material Definitive Agreement
28 Sep 10
8-K
Regulation FD Disclosure
15 Sep 10
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
31 Aug 10
8-K
Entry into a Material Definitive Agreement
26 Aug 10
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Aug 10
Registration and prospectus
15-12G
Securities registration termination
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
Proxies
DFAN14A
Additional proxy materials by non-management
13 Sep 10
DEFA14A
Additional proxy soliciting materials
4 May 10
DEF 14A
Definitive proxy
30 Apr 10
DEF 14A
Definitive proxy
30 Apr 09
PRE 14A
Preliminary proxy
16 Apr 09
DEF 14A
Definitive proxy
30 Apr 08
DEF 14A
Definitive proxy
30 Apr 07
DEF 14A
Definitive proxy
1 May 06
DEF 14A
Definitive proxy
27 Apr 05
DEF 14A
Definitive proxy
29 Jun 04
Other
CT ORDER
Confidential treatment order
29 Dec 11
EFFECT
Notice of effectiveness
18 Jan 11
EFFECT
Notice of effectiveness
18 Jan 11
EFFECT
Notice of effectiveness
18 Jan 11
EFFECT
Notice of effectiveness
18 Jan 11
UPLOAD
Letter from SEC
13 Dec 10
UPLOAD
Letter from SEC
13 Dec 10
UPLOAD
Letter from SEC
15 Nov 10
CORRESP
Correspondence with SEC
14 Oct 10
UPLOAD
Letter from SEC
7 Oct 10
Ownership
SC 13D
CYPRESS BIOSCIENCE / RP Management ownership change
23 Dec 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius Value & Opportunity ownership change
20 Dec 10
SC 13D/A
CYPRESS BIOSCIENCE / RA CAPITAL MANAGEMENT ownership change
30 Sep 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
20 Sep 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
16 Sep 10
SC 13D
CYPRESS BIOSCIENCE / RA CAPITAL MANAGEMENT ownership change
13 Sep 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
12 Aug 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
6 Aug 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
22 Jul 10
SC 13D
CYPRESS BIOSCIENCE / Ramius ownership change
19 Jul 10